ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,610, issued on June 30, was assigned to REPUBLIC OF KOREA (ANIMAL AND PLANT QUARANTINE AGENCY) (Gyeongsangbuk-do, South Korea) and Mississip... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,611, issued on June 30, was assigned to Pontificia Universidad Catolica de Chile (Santiago, Chile). "Use of BCG immunogenic formulation exp... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,612, issued on June 30, was assigned to NATIONAL HEALTH RESEARCH INSTITUTES (Zhunan Town, Taiwan) and FUJIFILM BIOSCIENCES INC. (Santa Ana, ... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,613, issued on June 30, was assigned to The Trustees of the University of Pennsylvania (Philadelphia). "Nucleoside-modified RNA for inducin... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,614, issued on June 30, was assigned to National University of Singapore (Singapore). "Bacterial microcompartment virus-like particles" was... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,615, issued on June 30, was assigned to UCB PHARMA S.A. (Brussels). "Treatment for bone diseases" was invented by Martyn K. Robinson (Shaft... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,617, issued on June 30, was assigned to NABORS ENERGY TRANSITION SOLUTIONS LLC (Houston). "Cancer treatment delivery component including a ... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,618, issued on June 30, was assigned to SAMYANG HOLDINGS Corp. (Seoul, South Korea). "Polymer nanoparticle composition for inducing immunit... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,619, issued on June 30, was assigned to Arrowhead Pharmaceuticals Inc. (Pasadena, Calif.). "Integrin targeting ligands and uses thereof" wa... Read More
ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,620, issued on June 30, was assigned to AVILAR THERAPEUTICS INC. (Waltham, Mass.). "ASGPR-binding compounds for the degradation of extracel... Read More